The long-term goal of this research is to understand the molecular mechanisms of drusen formation and Bruch's membrane thickening in age-related macular degeneration (AMD). The unifying hypothesis is that protein modifications are causally involved in both processes. Drusen are extracellular deposits that form between the retinal pigment epithelium and Bruch's membrane and confluent drusen are the hallmark risk factor for developing AMD. The progression of AMO might be slowed or halted if drusen and Bruch's membrane changes can be modulated. The proposed research will identify proteins and lipids in drusen and Bruch's membrane from healthy and AMD donor tissues and characterize associated protein modifications and reactive lipid fragments.
Four specific aims will test the following hypotheses: ? ? (i) that the drusen proteome differs among drusen sub-types; (ii) that the Bruch's membrane proteome varies with age and state of health; (iii) that lipid oxidation products in drusen and Bruch's membrane vary with age and state of health; (iv) that oxidative protein modifications contribute to drusen formation and Bruch's membrane thickening. Mass spectrometric methods will be used to identify and characterize proteins, phospholipids and lipid oxidation products. Immunocytochemistry will be used to confirm protein localization to drusen and Bruch's membrane. Western analyses, electrophoretic mobility shifts and bioinformatic tools will be used to detect protein modifications. The results will help establish a firm link between oxidative damage and the pathogenesis of AMD and provide new opportunities for developing strategies and therapies for preventing or limiting the complications of AMD.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY014239-05
Application #
6942253
Study Section
Special Emphasis Panel (ZRG1-VISC (01))
Program Officer
Dudley, Peter A
Project Start
2002-09-01
Project End
2008-08-31
Budget Start
2005-09-15
Budget End
2008-08-31
Support Year
5
Fiscal Year
2005
Total Cost
$377,500
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Tayou, Junior; Wang, Qiang; Jang, Geeng-Fu et al. (2016) Regulator of G Protein Signaling 7 (RGS7) Can Exist in a Homo-oligomeric Form That Is Regulated by G?o and R7-binding Protein. J Biol Chem 291:9133-47
Crabb, John W; Hu, Bo; Crabb, John S et al. (2015) iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors. PLoS One 10:e0135543
Crabb, John W (2014) The proteomics of drusen. Cold Spring Harb Perspect Med 4:a017194
Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E et al. (2013) CEP biomarkers as potential tools for monitoring therapeutics. PLoS One 8:e76325
Bollinger, Kathryn E; Crabb, John S; Yuan, Xianglin et al. (2012) Proteomic similarities in steroid responsiveness in normal and glaucomatous trabecular meshwork cells. Mol Vis 18:2001-11
Bollinger, Kathryn E; Crabb, John S; Yuan, Xianglin et al. (2011) Quantitative proteomics: TGF?? signaling in trabecular meshwork cells. Invest Ophthalmol Vis Sci 52:8287-94
Yuan, Xianglin; Gu, Xiaorong; Crabb, John S et al. (2010) Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes. Mol Cell Proteomics 9:1031-46
Crabb, John W; Yuan, Xianglin; Dvoriantchikova, Galina et al. (2010) Preliminary quantitative proteomic characterization of glaucomatous rat retinal ganglion cells. Exp Eye Res 91:107-10
Gu, Jiayin; Pauer, Gayle J T; Yue, Xiuzhen et al. (2010) Proteomic and genomic biomarkers for age-related macular degeneration. Adv Exp Med Biol 664:411-7
Gu, Jiayin; Pauer, Gayle J T; Yue, Xiuzhen et al. (2009) Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics 8:1338-49

Showing the most recent 10 out of 47 publications